Paper Details

  1. Home
  2. Paper Details

Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.

Author: BrookShlomo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Intramuscular ziprasidone, the first atypical antipsychotic in a rapid-acting intramuscular formulation, is an effective treatment for acutely ill patients with schizophrenia. It reduces agitation within 15 minutes and improves overall symptom severity compared to haloperidol.
Paper Details　
Original Abstract of the Article :
The appropriate management of schizophrenia and schizoaffective disorder requires effective, safe antipsychotic agents for use across a continuum of treatment, from control of acute psychotic episodes to prevention of relapse. Intramuscular (IM) formulations are the method of choice for administerin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/14728085

データ提供：米国国立医学図書館（NLM）

Intramuscular Ziprasidone: A New Approach for Acute Agitation in Schizophrenia

This study explores the use of intramuscular (IM) ziprasidone for the treatment of acute agitation in patients with schizophrenia. Ziprasidone is an atypical antipsychotic medication that has been shown to be effective in treating schizophrenia. The study reviews the efficacy and tolerability of IM ziprasidone in managing acute agitation in patients with schizophrenia.

IM Ziprasidone: A Rapid and Effective Solution for Acute Agitation

The study found that IM ziprasidone was effective in reducing agitation as early as 15 minutes after administration, with improvement sustained for several hours. The authors also reported that IM ziprasidone was superior to IM haloperidol in improving overall symptom severity in patients with acute psychosis, with or without agitation. These findings suggest that IM ziprasidone could be a valuable tool for managing acute agitation in patients with schizophrenia.

IM Ziprasidone: A Powerful Tool for Managing Schizophrenia

This research highlights the potential of IM ziprasidone as an effective and safe treatment for acute agitation in patients with schizophrenia. The ability to quickly reduce agitation can have a significant impact on patient care and overall well-being. Think of IM ziprasidone as a calming oasis in the desert of schizophrenia, offering a refuge from the storms of agitation and distress.

Dr. Camel's Conclusion

This study underscores the importance of having effective and safe treatment options for acute agitation in patients with schizophrenia. IM ziprasidone offers a promising new approach that can help manage this challenging condition. By providing a rapid and effective solution, we can improve the quality of life for patients and create a more peaceful and manageable environment for them to navigate the complexities of their illness.
Date :
  1. Date Completed 2004-02-17
  2. Date Revised 2022-03-17
Further Info :

Pubmed ID

14728085

DOI: Digital Object Identifier

14728085

Related Literature

Article Analysis
・Effects of ziprasidone injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.